|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2019. CA Cancer J Clin. 69:7–34. 2019.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Baek MH, Lee SW, Park JY, Rhim CC, Kim DY,
Suh DS, Kim JH, Kim YM, Kim YT and Nam JH: Preoperative predictive
factors for complete cytoreduction and survival outcome in
epithelial ovarian, tubal, and peritoneal cancer after neoadjuvant
chemotherapy. Int J Gynecol Cancer. 27:420–429. 2017.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Rehmani H, Li Y, Li T, Padia R, Calbay O,
Jin L, Chen H and Huang S: Addiction to protein kinase Cɩ due to
PRKCI gene amplification can be exploited for an aptamer-based
targeted therapy in ovarian cancer. Signal Transduct Target Ther.
5(140)2020.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Liang MI, Prendergast EN, Staples JN,
Holschneider CH, Cohen JG and Cass I: Prognostic role of pathologic
response and cytoreductive status at interval debulking surgery
after neoadjuvant chemotherapy for advanced epithelial ovarian
cancer. J Surg Oncol. 120:779–785. 2019.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Eggink FA, Koopmans CM and Nijman HW:
Surgery for patients with newly diagnosed advanced ovarian cancer:
Which patient, when and extent? Curr Opin Oncol. 29:351–358.
2017.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Kim SI, Hwang WY, Lee M, Kim HS, Kim K,
Chung HH, No JH, Kim JW, Kim YB, Park NH, et al: Survival impact of
extended cycles of second-line chemotherapy in platinum-sensitive
relapsed ovarian cancer patients with residual tumor after six
cycles. BMC Cancer. 20(1199)2020.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Lindemann K, Gao B, Mapagu C, Fereday S,
Emmanuel C, Alsop K and Traficante N: Australian Ovarian Cancer
Study Group. Harnett PR, Bowtell DDL and deFazio A: Response rates
to second-line platinum-based therapy in ovarian cancer patients
challenge the clinical definition of platinum resistance. Gynecol
Oncol. 150:239–246. 2018.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Bacalbasa N, Balescu I, Balalau C, Ionescu
O and Stoica C: Association of diaphragmatic surgery as part of
cytoreductive effort in advanced stage ovarian cancer. In Vivo.
32:431–436. 2018.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Pounds R, Phillips A, Kehoe S, Nevin J,
Sundar S, Elattar A, Teo HG, Singh K and Balega J: Diaphragm
disease in advanced ovarian cancer: Predictability of pre-operative
imaging and safety of surgical intervention. Eur J Obstet Gynecol
Reprod Biol. 226:47–53. 2018.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Grimm C, Harter P, Heitz F and du Bois A:
The sandwich technique of diaphragmatic stripping or full-thickness
resection for advanced ovarian cancer: How to keep it short and
simple. Int J Gynecol Cancer. 25:131–134. 2015.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Majd HS, Ferrari F, Manek S, Gubbala K,
Campanile RG, Hardern K and Tozzi R: Diaphragmatic peritonectomy
vs. full thickness resection with pleurectomy during
visceral-peritoneal debulking (VPD) in 100 consecutive patients
with stage IIIC-IV ovarian cancer: A surgical-histological
analysis. Gynecol Oncol. 140:430–435. 2016.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Panuccio E, Leunen K, Van Nieuwenhuysen E,
Neven P, Lambrechts S and Vergote I: Use of plasmajet for
peritoneal carcinomatosis in ovarian cancer. Int J Gynecol Cancer.
26:1521–1524. 2016.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Kehoe SM, Eisenhauer EL and Chi DS: Upper
abdominal surgical procedures: Liver mobilization and diaphragm
peritonectomy/resection, splenectomy, and distal pancreatectomy.
Gynecol Oncol. 111 (Suppl 2):S51–S55. 2008.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Prat J: FIGO Committee on Gynecologic
Oncology. Staging classification for cancer of the ovary, fallopian
tube, and peritoneum. Int J Gynaecol Obstet. 124:1–5.
2014.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Oken MM, Creech RH, Tormey DC, Horton J,
Davis TE, McFadden ET and Carbone PP: Toxicity and response
criteria of the eastern cooperative oncology group. Am J Clin
Oncol. 5:649–656. 1982.PubMed/NCBI
|
|
16
|
Dindo D, Demartines N and Clavien PA:
Classification of surgical complications: A new proposal with
evaluation in a cohort of 6336 patients and results of a survey.
Ann Sur. 240:205–213. 2004.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Parsa M: Retroperitoneal dissection of
ovarian endometrioma using J-Plasma technology. J Minim Invasive
Gynecol. 22(S140)2015.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Renaud MC and Sebastianelli A: Optimal
cytoreduction with neutral argon plasma energy in selected patients
with ovarian and primitive peritoneal cancer. J Obstet Gynaecol
Can. 35:49–52. 2013.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Sonoda Y, Olvera N, Chi DS, Brown CL,
Abu-Rustum NR and Levine DA: Pathologic analysis of ex vivo plasma
energy tumor destruction in patients with ovarian or peritoneal
cancer. Int J Gynecol Cancer. 20:1326–1330. 2010.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Prodromidou A, Pandraklakis A and Iavazzo
C: The emerging role of neutral argon plasma (PlasmaJet) in the
treatment of advanced stage ovarian cancer: A systematic review.
Surg Innov. 27:299–306. 2020.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Eskander RN, Kauderer J, Tewari KS, Mannel
RS, Bristow RE, O'Malley DM, Rubin SC, Glaser GE, Hamilton CA,
Fujiwara K, et al: Correlation between Surgeon's assessment and
radiographic evaluation of residual disease in women with advanced
stage ovarian cancer reported to have undergone optimal surgical
cytoreduction: An NRG oncology/gynecologic oncology group study.
Gynecol Oncol. 149:525–530. 2018.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Muallem MZ, Almuheimid J, Richter R,
Braicu EI, Osman S and Sehouli J: Diaphragmatic surgery in advanced
ovarian, tubal and peritoneal cancer. A 7-year retrospective
analysis of the tumor bank ovarian cancer network. Anticancer Res.
36:4707–4713. 2016.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Tsolakidis D, Amant F, Van Gorp T, Leunen
K, Neven P and Vergote I: Diaphragmatic surgery during primary
debulking in 89 patients with stage IIIB-IV epithelial ovarian
cancer. Gynecol Oncol. 116:489–496. 2010.PubMed/NCBI View Article : Google Scholar
|
